Caxton Associates (New York)’s Omnicell OMCL Stock Holding History

Caxton Associates (New York)’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-36,244	Closed	-$1.06M	–	565
2024 Q1	$1.06M	Sell	36,244 -19,949	-36%	-$605K	0.06%	212
2023 Q4	$2.11M	Buy	+56,193	New	+$2.07M	0.11%	118
2022 Q4	–	Sell	-6,381	Closed	-$555K	–	572
2022 Q3	$555K	Buy	+6,381	New	+$670K	0.07%	217
2019 Q3	–	Sell	-4,061	Closed	-$349K	–	499
2019 Q2	$349K	Hold	4,061	–	–	0.04%	258
2019 Q1	$328K	Buy	+4,061	New	+$304K	0.05%	230

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caxton Associates (New York)'s OMCL Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Omnicell (OMCL) in Q2 2024, closing a stake of 36,244 shares — an estimated $1.06M sold.

Caxton Associates (New York) first reported a position in OMCL in Q1 2019 and held it in 5 quarters. The position peaked at $2.11M in Q4 2023. 240 funds tracked by Wall St. Rank hold OMCL as of Q2 2024.

Caxton Associates (New York) reported no remaining Omnicell position as of Q2 2024 after selling out during the quarter.
Caxton Associates (New York) sold 36,244 Omnicell shares in Q2 2024, an estimated $1.06M.
Caxton Associates (New York) first reported a position in Omnicell in Q1 2019 and held it in 5 quarters.
Caxton Associates (New York)'s Omnicell position peaked at $2.11M in Q4 2023.
240 funds tracked by Wall St. Rank held Omnicell as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.